Sep 7, 2026, 15:35
Abdulaziz Hamoudi: The Multicenter Randomized PROTECT-EST Trial Reports Impressive Results for SAP
Abdulaziz Hamoudi, Business Development Manager at ENDOHUB group, shared a post on LinkedIn:
”Peptide-first for post-sphincterotomy bleeding?
The multicenter randomized PROTECT-EST trial reports impressive results for self-assembling peptide (SAP) in persistent post-sphincterotomy oozing:
- 92.3 percent immediate hemostasis vs 76.9 percent with balloon tamponade
- 7.7 percent required rescue therapy vs 23.1 percent
Promising evidence supporting a peptide-first strategy in therapeutic endoscopy.
Proud to support the advancement of PuraStat self-assembling peptide technology in our region.
Study.”
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters